The CKD Anemia market in 7MM offers growth opportunities due to rising diagnosed cases, unmet clinical needs, and a promising late-stage pipeline. Strategic partnerships and in-licensing could ...
Acquires next generation tissue-targeted C3d-Factor H fusion protein complement inhibitor from Q32 Bio Phase 2 basket trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback